Vasoreparative potential of endothelial progenitor cells is enhanced by a novel erythropoietin (EPO) mimetic peptide.
Olivia O'Leary(Queen's University Belfast), Alan W. Stitt(Queen's University Belfast), Reinhold J. Medina(Queen's University Belfast), Anthony Cerami(Araim Pharmaceuticals (United States)), Michael Brines(Northwell Health), Derek P. Brazil(Queen's University Belfast)
Research Portal (Queen's University Belfast)
April 1, 2015
Cited by 0
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
|JCI Insight|2017|1k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k